Investment Trusts

Bellevue Healthcare Trust plc

BBH:LSE

Bellevue Healthcare Trust plc

  • Price (GBX)146.00
  • Today's Change0.60 / 0.41%
  • Shares traded2.10m
  • 1 Year change9.77%
  • Beta0.8181
Data delayed at least 15 minutes, as of Oct 04 2024 16:35 BST.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceBellevue Healthcare Trust plc (Ordinary Share)+12.65%
NAVBellevue Healthcare Trust plc (Ordinary Share)+14.36%
Morningstar's BenchmarkMSCI World HealthCare TR GBP--

Key statistics

On Friday, Bellevue Healthcare Trust plc (BBH:LSE) closed at 146.00, -8.64% below its 52-week high of 159.80, set on Jan 02, 2024.
52-week range
Today
119.40Nov 13 2023159.80Jan 02 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding451.83m
Market cap657.21m GBP
Total assets728.67m GBP
Total expense ratio1.01%
High146.40
Low144.20
Previous close145.40
Average volume1.35m
YTD Change-7.24%
Beta0.8181
Diluted NAV (est)160.03
Diluted NAV (last pub)160.63
Premium/Discount-8.77%
Net Gearing0.00%
Annual div (ADY)5.52 GBX
Annual div yield (ADY)3.78%
Div ex-dateAug 01 2024
Div pay-dateAug 29 2024
Data delayed at least 15 minutes, as of Oct 04 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.